{"id":14383,"date":"2015-06-18T10:33:53","date_gmt":"2015-06-18T09:33:53","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=14383"},"modified":"2015-06-18T10:33:53","modified_gmt":"2015-06-18T09:33:53","slug":"actualitzacio-en-anticoagulants-orals","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/","title":{"rendered":"Actualitzaci\u00f3 en anticoagulants orals"},"content":{"rendered":"<p>M\u00e9s de 200 farmac\u00e8utics dels tres \u00e0mbits assistencials -hospital, prim\u00e0ria i comunit\u00e0ria- van assistir de manera presencial o via on-line a la jornada \u201cActualitzaci\u00f3 en anticoagulants orals (ACO)\u201d que va tenir lloc el 6 de maig al Col\u00b7legi. Dirigida a farmac\u00e8utics d\u2019aquestes tres \u00e0rees de treball, va estar organitzada conjuntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica. Es va intentar donar una visi\u00f3 conjunta sobre la <strong>utilitzaci\u00f3 dels anticoagulants orals des del punt de vista dels diferents nivells assistencials implicats en la seva indicaci\u00f3 i seguiment<\/strong>. Es va incidir sobretot en el paper que actualment tenen els<strong> anticoagulants orals directes (DACO<\/strong>) i quines implicacions cl\u00edniques i econ\u00f2miques t\u00e9 la seva <strong>utilitzaci\u00f3 com alternativa als tradicionals inhibidors de la vitamina K (AVK)<\/strong>.<\/p>\n<figure id=\"attachment_14393\" aria-describedby=\"caption-attachment-14393\" style=\"width: 554px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/06\/jornada-anticoagulants-orals.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\" wp-image-14393 \" alt=\"jornada-anticoagulants-orals\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/06\/jornada-anticoagulants-orals.jpg\" width=\"554\" height=\"295\" \/><\/a><figcaption id=\"caption-attachment-14393\" class=\"wp-caption-text\">D&#8217;esquerra a dreta: Xavier Garcia, Marta Duero, Roser Vall\u00e8s i Meritxell Boquet<\/figcaption><\/figure>\n<div class=\"box shadow\"><strong>Sigles de refer\u00e8ncia<\/strong>:<br \/>\nACO: anticoagulants orals<br \/>\nDACO: anticoagulants orals directes<br \/>\nFA: fibril\u00b7laci\u00f3 auricular<br \/>\nNACO: anticoagulants nous<br \/>\nAVK: antagonistes de la vitamina K<\/div>\n<p><span style=\"color: #808080;\">Durant d\u00e8cades, els antagonistes de la vitamina K (AVK) han estat l\u2019\u00fanica opci\u00f3 disponible de la ter\u00e0pia anticoagulant oral per prevenir les complicacions tromboemb\u00f2liques. En els \u00faltims anys s\u2019han desenvolupat medicaments anticoagulants nous (NACO) que han demostrat un benefici-risc favorable en diverses condicions cl\u00edniques en qu\u00e8 est\u00e0 indicada aquesta medicaci\u00f3.<\/span><\/p>\n<p><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/06\/roser-valles-jornada-anticoagulants-orals.jpg\"><img decoding=\"async\" class=\"wp-image-14391 alignright\" alt=\"roser-valles-jornada-anticoagulants-orals\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/06\/roser-valles-jornada-anticoagulants-orals.jpg\" width=\"298\" height=\"199\" \/><\/a><div class=\"box shadow\">\u201cUna de les principals conclusions que vam poder extreure \u00e9s que <b>la ter\u00e0pia amb anticoagulants orals aporta un benefici clar als pacients amb fibril\u00b7laci\u00f3 auricular (FA) que tenen indicat aquest tipus de tractament per\u00f2 en contrapartida encara no disposem de l\u2019ACO ideal<\/b>. Els DACO aporten avantatges comparats amb els AVK (concretament amb el Sintrom) des del punt de vista de comoditat i estabilitat en la dosificaci\u00f3 i amb el perill de variabilitat dels nivells plasm\u00e0tics del f\u00e0rmac, sigui per interaccions o per altres motius metab\u00f2lics, per\u00f2 tenen aspectes que de moment no tenen resolts: la seva seguretat a llarg termini (sobretot en el seguiment de la funci\u00f3 renal, el risc d\u2019hemorr\u00e0gies gastrointestinals, etc.) i en l\u2019impacte econ\u00f2mic de la introducci\u00f3 d\u2019aquests f\u00e0rmacs no nom\u00e9s pel sistema sanitari sin\u00f3 tamb\u00e9 per als propis pacients amb pocs recursos econ\u00f2mics\u201d explica <b>Roser Vall\u00e8s, vocal d\u2019Atenci\u00f3 Prim\u00e0ria del Col\u00b7legi i moderadora de la taula rodona<\/b>.<\/div><\/p>\n<p><strong>Una de les indicacions m\u00e9s prevalent en la utilitzaci\u00f3 dels ACO \u00e9s la fibril\u00b7laci\u00f3 auricular (FA)<\/strong>, per tant la Jornada es va centrar principalment en aquesta. Com expert en aquest tema,\u00a0 <b>Xavier Garcia<\/b>, cap cl\u00ednic del servei de cardiologia de l\u2019Hospital de la Santa Creu i Sant Pau, va explicar per qu\u00e8 \u00e9s necessari descoagular a la majoria de pacients amb FA i quins beneficis ens aporten els ACO per evitar futures complicacions en pacients amb aquesta patologia. Seguidament <b>Marta Duero<\/b>, farmac\u00e8utica del servei de farm\u00e0cia de l\u2019Hospital Universitari Vall d\u2019Hebron, va presentar les caracter\u00edstiques farmacol\u00f2giques dels diferents tipus d\u2019ACO i quines evid\u00e8ncies cient\u00edfiques tenim actualment sobre els f\u00e0rmacs m\u00e9s nous d\u2019aquest grup terap\u00e8utic, els DACO, tant a nivell d\u2019efic\u00e0cia com de seguretat. I tancant aquesta primera part de la jornada, <b>Meritxell Boquet<\/b>, farmac\u00e8utica comunit\u00e0ria de Ripollet, va explicar, amb exemples reals, quins problemes tenen els pacients en el seguiment i adher\u00e8ncia del seu tractament amb ACO i les difer\u00e8ncies que hi ha entre els pacients amb AVK i els pacients amb DACO. En la segona part de la Jornada, <b>Llu\u00eds Seg\u00fa<\/b>, farmac\u00e8utic economista de la salut, va intentar aclarir els principals conceptes de les an\u00e0lisis cost-utilitat a l\u2019hora de valorar l\u2019impacte econ\u00f2mic de la utilitzaci\u00f3 de determinades ter\u00e0pies farmacol\u00f2giques i concretament en l\u2019an\u00e0lisi de l\u2019impacte econ\u00f2mic que t\u00e9 en el sistema sanitari els DACO.<\/p>\n<p align=\"right\"><b>Amb la col\u00b7laboraci\u00f3 de:<\/b><\/p>\n<p align=\"right\"><a href=\"http:\/\/www.daiichi-sankyo.es\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"alignright  wp-image-14385\" alt=\"logo lab daiichi\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/06\/logo-lab-daiichi.jpg\" width=\"196\" height=\"37\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>M\u00e9s de 200 farmac\u00e8utics dels tres \u00e0mbits assistencials -hospital, prim\u00e0ria i comunit\u00e0ria- van assistir de manera presencial o via on-line a la jornada \u201cActualitzaci\u00f3 en anticoagulants orals (ACO)\u201d que va tenir lloc el 6 de maig al Col\u00b7legi. Dirigida a farmac\u00e8utics d\u2019aquestes tres \u00e0rees de treball, va estar organitzada conjuntament [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":14393,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[1010,938,68,70,481],"class_list":["post-14383","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-anticoagulants-orals","tag-atencio-primaria","tag-farmacia","tag-formacio","tag-hospitals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Actualitzaci\u00f3 en anticoagulants orals - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Actualitzaci\u00f3 en anticoagulants orals - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"M\u00e9s de 200 farmac\u00e8utics dels tres \u00e0mbits assistencials -hospital, prim\u00e0ria i comunit\u00e0ria- van assistir de manera presencial o via on-line a la jornada \u201cActualitzaci\u00f3 en anticoagulants orals (ACO)\u201d que va tenir lloc el 6 de maig al Col\u00b7legi. Dirigida a farmac\u00e8utics d\u2019aquestes tres \u00e0rees de treball, va estar organitzada conjuntament [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-06-18T09:33:53+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Actualitzaci\u00f3 en anticoagulants orals\",\"datePublished\":\"2015-06-18T09:33:53+00:00\",\"dateModified\":\"2015-06-18T09:33:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/\"},\"wordCount\":679,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"anticoagulants orals\",\"Atenci\u00f3 prim\u00e0ria\",\"Farm\u00e0cia\",\"Formaci\u00f3\",\"Hospitals\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/\",\"name\":\"Actualitzaci\u00f3 en anticoagulants orals - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2015-06-18T09:33:53+00:00\",\"dateModified\":\"2015-06-18T09:33:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actualitzaci\u00f3 en anticoagulants orals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Actualitzaci\u00f3 en anticoagulants orals - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/","og_locale":"ca_ES","og_type":"article","og_title":"Actualitzaci\u00f3 en anticoagulants orals - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"M\u00e9s de 200 farmac\u00e8utics dels tres \u00e0mbits assistencials -hospital, prim\u00e0ria i comunit\u00e0ria- van assistir de manera presencial o via on-line a la jornada \u201cActualitzaci\u00f3 en anticoagulants orals (ACO)\u201d que va tenir lloc el 6 de maig al Col\u00b7legi. Dirigida a farmac\u00e8utics d\u2019aquestes tres \u00e0rees de treball, va estar organitzada conjuntament [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2015-06-18T09:33:53+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"3 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Actualitzaci\u00f3 en anticoagulants orals","datePublished":"2015-06-18T09:33:53+00:00","dateModified":"2015-06-18T09:33:53+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/"},"wordCount":679,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/#primaryimage"},"thumbnailUrl":"","keywords":["anticoagulants orals","Atenci\u00f3 prim\u00e0ria","Farm\u00e0cia","Formaci\u00f3","Hospitals"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/","url":"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/","name":"Actualitzaci\u00f3 en anticoagulants orals - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/#primaryimage"},"thumbnailUrl":"","datePublished":"2015-06-18T09:33:53+00:00","dateModified":"2015-06-18T09:33:53+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2015\/06\/18\/actualitzacio-en-anticoagulants-orals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Actualitzaci\u00f3 en anticoagulants orals"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"M\u00e9s de 200 farmac\u00e8utics dels tres \u00e0mbits assistencials -hospital, prim\u00e0ria i comunit\u00e0ria- van assistir de manera presencial o via on-line a la jornada \u201cActualitzaci\u00f3 en anticoagulants orals (ACO)\u201d que va tenir lloc el 6 de maig al Col\u00b7legi. Dirigida a farmac\u00e8utics d\u2019aquestes tres \u00e0rees de treball, va estar organitzada conjuntament [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/14383","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=14383"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/14383\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=14383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=14383"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=14383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}